FMC Stock Recent News

FMC (FMC) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

PHILADELPHIA , July 16, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today that its board of directors declared a regular quarterly dividend of 58 cents per share, payable on October 16, 2025, to shareholders of record as of the close of business on September 30, 2025. About FMC FMC Corporation is a global agricultural sciences company dedicated to helping growers produce food, feed, fiber and fuel for an expanding world population while adapting to a changing environment.

NEW YORK, July 07, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE:FMC) on behalf of long-term stockholders following a class action complaint that was filed against FMC on May 29, 2025 with a Class Period from November 16, 2023 to February 4, 2025. Our investigation concerns whether the board of directors of FMC have breached their fiduciary duties to the company.

Investors interested in stocks from the Agriculture - Operations sector have probably already heard of FMC (FMC) and Corteva, Inc. (CTVA). But which of these two companies is the best option for those looking for undervalued stocks?

FMC (FMC) has an impressive earnings surprise history and currently possesses the right combination of the two key ingredients for a likely beat in its next quarterly report.

FMC launches Tremisia fungicide in Ukraine, bringing fluindapyr tech to EMEA growers battling major crop diseases.

Tremisia® fungicide receives registration in Ukraine, bringing growers a new tool to combat challenging crop diseases PHILADELPHIA , June 30, 2025  /PRNewswire/ -- FMC Corporation (NYSE: FMC), a leading global agricultural sciences company, today announced regulatory approval for Tremisia® fungicide in Ukraine, marking the first introduction of the company's novel fluindapyr technology in the European, Middle East, and Africa (EMEA) region. The approval covers oilseed rape, sunflower, and wheat across more than 10 million hectares of Ukrainian farmland.

We assess FMC Corporation as a Hold to moderate buy, downgrading from a previous buy opportunity due to weak growth, momentum, and financial potential. FMC's strengths are its innovation, R&D focus, and attractive 5.4% dividend yield, but revenue and profit have declined for several years. FMC valuation is fair around $50 per share, but insider and hedge fund selling, high debt, and weak near-term growth limit upside.

PHILADELPHIA , June 19, 2025 /PRNewswire/ -- FMC Corporation (NYSE: FMC) announced today it will release its second quarter 2025 earnings on Wednesday, July 30, 2025, after the stock market close via PR Newswire and the company's website https://investors.fmc.com. The company will host a webcast conference call on Thursday, July 31, 2025, at 9:00 a.m.

NEW YORK, June 17, 2025 (GLOBE NEWSWIRE) -- Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potential claims against FMC Corporation (NYSE:FMC) on behalf of long-term stockholders following a class action complaint that was filed against FMC on February 13, 2025 with a Class Period from November 16, 2023 to February 4, 2025.